Trujillo MF

Language: Spanish
References: 22
Page: 151-154
PDF size: 153.53 Kb.

ABSTRACT

Objective: To assess whether the administration of topical ceftazidime decreases hearing after treatment in patients with non-cholesteatomatous chronic otitis media.
Material and method: An observational, longitudinal, ambispective and analytical study was conducted at the otorhinolaryngology, and head neck surgical ward at the highly specialized medical unit of the La Raza General Hospital National Medical Center in Mexico City from January 1998 to September 2002. The study group was comprised by patients diagnosed with non-cholesteatomatous chronic otitis media that were administered ototopic treatment with ceftazidime drops. Age, gender, disease evolution and co-morbidity were controlled. A hearing test was done before and 30 days after treatment using a Madzen Minimate 602 brand audiometer. A statistical analysis was done using SPSS statistical software version 10.0.
Results: 50 patients were studied. No statistically significant differences were found in the degree of hearing after the administration of the drug: p › 0.48, CI: 0.96-1.13 and RR = 1.1.
Conclusions: The ototopical administration of ceftazidime does not produce a decrease in hearing after treatment.

REFERENCES

1. Morden N, Berke E. Topical fluoroquinolones for eye and ear. Am Fam Physician 2000;62(8):1870-6.

2. Esposito S, D’Errico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin. Arch Otolaryngol Head Neck Surg 1990;116:557-9.

3. Brownlee R, Hulka G, Prazma J, Pillsbury H. Ciprof loxacin. Use as a topical otic preparation. Arch Otola r y ngol Head Neck Su rg 1992;118:392-6.

4. Dohar J, Cuneyt A, Rose E, et al. Treatment of chronic suppurative otitis media with topical ciprofloxacin. Ann Otol Rhinol Laryngol 1998;107:865-71.

5. Alper C, Dohar J, Gulhan M, et al. Treatment of chronic suppurative otitis media with topical tobramycin and dexamethasone. Arch Otolaryngol Head Neck Surg 2000;126:165-73.

6. Kiris M, Berktas M, Egeli E, Kutluhan A. The efficacy of topical ciprofloxacin in the tratment of chronic suppurative otitis media. Ear Nose Troth J 1998;77(11):904-9.

7. Esposito S, Noviello S, D’Errico G, Montanaro C. Topical ciprofloxacin vs intramuscular gentamicin for chronic otitis media. Arch Otolaryngol Head Neck Surg 1992;118:842-4.

8. Aslan A, Altuntas A, Titiz A, et al. A new dosage regimen for topical application of ciprofloxacin in the management of chronic suppurative otitis media. Otolaryngol Head Neck Surg 1998;118:883-5.

9. Lancaster JL, Makura ZGG, Porter G, McCormick M. Topical aminoglycosides in the management of active mucosal chronic suppurative otitis media. J Laryngol Otol 1999;113:10-12.

10. Fradis M, Brodsky A, Ben-David J, et al. Chronic otitis media treated topically with ciprofloxacin or tobramycin. Arch Otolaryngol Head Neck Surg 1997;123:1057-60.

11. Green J, Ed S, Lappin P, Curley A, De Carpentier JP. Systemic absorption of gentamicin ear drops. J Laringol Otol 1997;111:960-2.

12. Jinn TH, Kim P, Russel P, et al. Determination of ototoxicity of common otic drops using isolated cochlear outer hair cells. Laryngoscope 2001;111:2105-8.

13. Claes J, Van de Heyning P, Creten W, Van Hoof M. Side effects of repeated ototopical application of fosfomycin. Arch Otolaryngol Head Neck Surg 1992;118:951-5.

14. Meyerhoff W, Wruight C. Ototoxicity of otitis drops applied to the middle ear in chinchilla. Am J Otolaryngol 1984;5:166-76.

15. Brown OE, Wright CG, Edwards LB, Meyerhoff WL. The ototoxicity of ceftazidime in the chinchilla middle ear. Arch Otolaryngol Head Neck Surg 1989;115(8):940-2.

16. Sackett LD, Haynes RB, Tugwell P. Cumplimiento en epidemiología clínica. New York: Little, Brown and Company, 1985;pp:259-88.

17. Hulley S. Diseño de la investigación clonica: Un enfoque epidemiológico. Barcelona: Doyma, 1993.

18. Indudaran R, Ashraful J, Subramania A. Antibiotic in chronic suppurative otitis media: a bacteriologic study. Ann Otol Rhinol Laryngol 1999;108:440-5.

19. Bégué P, Garabédian E, Bertrand C, et al. Penetration of ceftazidime into middle ear fluid in children with otitis media with efussion. Laryngoscope 1998;108:662-4.

20. O’Donoghue M, Green HT, Makenzie JJ, et al. Ceftazidime in middle ear fluid. J Antimicrob Chemother 1989;23:664-6.

21. Sun A H, Par nes LS, Freeman DJ. Comparative perilymph permeability of cefhalosporins and its significance in the treatment and prevention of suppurative labyrinthitis. Ann Otol Rhinol Laryngol 1996;105:54-7.

22. Gracia VP, Asenjo VP. Are some ear drops ototoxic or potentially ototoxic? Acta Otolaryngol 2001;121:565-8.